Peter Justin Klein
CIK 1608710 · last filed 2021-06-04
Peter Justin Klein is a corporate insider who has filed 26 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for PHAS, was dated Jun 4, 2021. Current disclosed insider exposure totals $2.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.65M
2
26
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | 2,303 | $0.07 | $161 | $0 | 5 | 2021-06-04 |
| SENS | Director | 369,186 | $7.18 | $2.65M | $0 | 21 | 2021-04-05 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-04 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-05 | SENS | Grant (A) | +2,470 | $6.4K | EDGAR |
| 2021-01-06 | SENS | Grant (A) | +6,853 | $6.4K | EDGAR |
| 2020-10-05 | SENS | Grant (A) | +16,375 | $6.4K | EDGAR |
| 2020-08-20 | SENS | Grant (A) | +273,077 | $0 | EDGAR |
| 2020-07-22 | SENS | Grant (A) | +273,077 | $0 | EDGAR |
| 2020-07-02 | SENS | Grant (A) | +16,905 | $6.4K | EDGAR |
| 2020-06-05 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-03 | SENS | Grant (A) | +11,184 | $6.4K | EDGAR |
| 2020-01-06 | SENS | Grant (A) | +6,959 | $6.4K | EDGAR |